|
FY2025
12 months to Dec 31, 2025
|
FY2024
6 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net Income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Payment of formation costs through issuance of Class B Ordinary Shares | ||
| Payment of operation costs through IPO Promissory Note-related party | ||
| Payment of operation costs through IPO Promissory Note - related party | ||
| Interest earned on cash and securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Due from Sponsor | ||
| Long-term prepaid insurance | ||
| Accounts payables and accrued expenses | ||
| Accrued offering costs | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Investment of cash into Trust Account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from sale of Public Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placement Units | ||
| Repayment of IPO Promissory Note-related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash - Beginning of period | ||
| Cash - End of period | ||
| Supplemental disclosure of noncash investing and financing activities: | ||
| Deferred offering costs included in accrued offering costs | ||
| Deferred offering costs paid through IPO Promissory Note-related party | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B Ordinary Shares | ||
| Accretion of Class A Ordinary Shares to redemption value | ||
| Deferred underwriting fee payable |
Loading...
